156 related articles for article (PubMed ID: 11073767)
1. Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman.
Lee FS; Chu FK; Tackley M; Wu AD; Atri A; Wessels MR
Clin Infect Dis; 2000 Nov; 31(5):1288-91. PubMed ID: 11073767
[TBL] [Abstract][Full Text] [Related]
2. Fourth nerve palsy caused by Ehrlichia chaffeensis.
Carter N; Miller NR
J Neuroophthalmol; 1997 Mar; 17(1):47-50. PubMed ID: 9093962
[TBL] [Abstract][Full Text] [Related]
3. Direct cultivation of the causative agent of human granulocytic ehrlichiosis.
Goodman JL; Nelson C; Vitale B; Madigan JE; Dumler JS; Kurtti TJ; Munderloh UG
N Engl J Med; 1996 Jan; 334(4):209-15. PubMed ID: 8531996
[TBL] [Abstract][Full Text] [Related]
4. [First detection of Ehrlichiosis detected serologically and with the polymerase chain reaction in patients with borreliosis in the Czech Republic].
Hulínská D; Kurzová D; Drevová H; Votýpka J
Cas Lek Cesk; 2001 Mar; 140(6):181-4. PubMed ID: 11347209
[TBL] [Abstract][Full Text] [Related]
5. First European pediatric case of human granulocytic ehrlichiosis.
Arnez M; Petrovec M; Lotric-Furlan S; Zupanc TA; Strle F
J Clin Microbiol; 2001 Dec; 39(12):4591-2. PubMed ID: 11724894
[TBL] [Abstract][Full Text] [Related]
6. Rapid and sensitive PCR-based detection and differentiation of aetiologic agents of human granulocytotropic and monocytotropic ehrlichiosis.
Chu FK
Mol Cell Probes; 1998 Apr; 12(2):93-9. PubMed ID: 9633044
[TBL] [Abstract][Full Text] [Related]
7. Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response.
Ijdo JW; Sun W; Zhang Y; Magnarelli LA; Fikrig E
Infect Immun; 1998 Jul; 66(7):3264-9. PubMed ID: 9632594
[TBL] [Abstract][Full Text] [Related]
8. Quantification of the human granulocytic ehrlichiosis agent based on analysis of rRNA isolated from control and infected HL-60 cells.
Wu JM; Whyzmuzis CA; Bertone MG; Zhou BS; Hsieh TC
Biochem Biophys Res Commun; 1999 Aug; 262(1):7-13. PubMed ID: 10448059
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of human granulocytic ehrlichiosis infection in Belgium.
Guillaume B; Heyman P; Lafontaine S; Vandenvelde C; Delmée M; Bigaignon G
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):397-400. PubMed ID: 12072927
[TBL] [Abstract][Full Text] [Related]
10. Polymerase chain reaction in detection of human granulocytic ehrlichiosis (HGE) agent DNA in Ixodes ricinus ticks.
Skotarczak B; Rymaszewska A; Adamska M
Folia Med Cracov; 2003; 44(1-2):179-86. PubMed ID: 15232900
[TBL] [Abstract][Full Text] [Related]
11. Infection of mice with the agent of human granulocytic ehrlichiosis after different routes of inoculation.
Hodzic E; Feng S; Fish D; Leutenegger CM; Freet KJ; Barthold SW
J Infect Dis; 2001 Jun; 183(12):1781-6. PubMed ID: 11372031
[TBL] [Abstract][Full Text] [Related]
12. A single tissue culture system for the propagation of the agents of the human ehrlichioses.
Heimer R; Tisdale D; Dawson JE
Am J Trop Med Hyg; 1998 Jun; 58(6):812-5. PubMed ID: 9660470
[TBL] [Abstract][Full Text] [Related]
13. Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1.
Barnewall RE; Ohashi N; Rikihisa Y
Infect Immun; 1999 May; 67(5):2258-65. PubMed ID: 10225882
[TBL] [Abstract][Full Text] [Related]
14. Tick-borne ehrlichiosis infection in human beings.
Ganguly S; Mukhopadhayay SK
J Vector Borne Dis; 2008 Dec; 45(4):273-80. PubMed ID: 19248653
[TBL] [Abstract][Full Text] [Related]
15. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells.
Mott J; Barnewall RE; Rikihisa Y
Infect Immun; 1999 Mar; 67(3):1368-78. PubMed ID: 10024584
[TBL] [Abstract][Full Text] [Related]
16. The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines.
Klein MB; Hu S; Chao CC; Goodman JL
J Infect Dis; 2000 Jul; 182(1):200-5. PubMed ID: 10882598
[TBL] [Abstract][Full Text] [Related]
17. Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE).
Hsieh TC; Aguero-Rosenfeld ME; Wu JM; Ng C; Papanikolaou NA; Varde SA; Schwartz I; Pizzolo JG; Melamed M; Horowitz HW; Nadelman RB; Wormser GP
Biochem Biophys Res Commun; 1997 Mar; 232(2):298-303. PubMed ID: 9125168
[TBL] [Abstract][Full Text] [Related]
18. Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics.
Standaert SM; Yu T; Scott MA; Childs JE; Paddock CD; Nicholson WL; Singleton J; Blaser MJ
J Infect Dis; 2000 Mar; 181(3):1082-8. PubMed ID: 10720534
[TBL] [Abstract][Full Text] [Related]
19. Human ehrlichiosis in central Europe.
Lotric-Furlan S; Petrovec M; Avsic-Zupanc T; Nicholson WL; Sumner JW; Childs JE; Strle F
Wien Klin Wochenschr; 1998 Dec; 110(24):894-7. PubMed ID: 10048172
[TBL] [Abstract][Full Text] [Related]
20. Human granulocytic ehrlichiosis in Northern California: two case descriptions with genetic analysis of the Ehrlichiae.
Foley JE; Crawford-Miksza L; Dumler JS; Glaser C; Chae JS; Yeh E; Schnurr D; Hood R; Hunter W; Madigan JE
Clin Infect Dis; 1999 Aug; 29(2):388-92. PubMed ID: 10476747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
